Atlas Trials

Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder

Clinical trial NCT03872596 · COMPLETED

Trial details

NCT number
NCT03872596
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bipolar DisorderSchizophrenia
Start date
2019-03-27
Primary completion
2019-10-30
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.